How do experts assess ‘chemo brain’?

How do experts assess ‘chemo brain’?

Posted by  | treatment

*The information in this blog post is based on the webinar, “Understanding Cancer-related Cognitive Impairment,” hosted by the Kimmel Cancer Center's Breast Cancer Program. Q: What type of cognitive assessments can be done for cancer patients undergoing treatment or who have completed treatment who complain about ‘chemo brain’? A: Tracy Vannorsdall, Ph.D., a neuropsychologist at Johns Hopkins(...)

Top Questions Ahead for Cancer Immunotherapy

Top Questions Ahead for Cancer Immunotherapy

Posted by  | Research

A decade ago, Suzanne Topalian, M.D., led a team of researchers who made an astonishing contribution to how cancer is fought. Many cancers can “put the brakes” on the body’s immune cells — cells that would normally storm into a tumor and destroy it. Topalian, director of the Melanoma Program at the Johns Hopkins Kimmel(...)

8 Tips for Improving Cognition During and After Cancer Treatment

Posted by  | Survivorship, treatment

*The information in this blog post is based on the webinar, “Understanding Cancer-related Cognitive Impairment,” hosted by the Kimmel Cancer Center's Breast Cancer Program. Q: What can I do to improve my cognition during and after cancer treatment? A: Use areas of cognitive strength to compensate for any weaknesses, advises Tracy Vannorsdall, PhD, a neuropsychologist at(...)

Kimmel Cancer Center Director Moderates AACR Webinar on Cancer Screening Guidelines

Kimmel Cancer Center Director Moderates AACR Webinar on Cancer Screening Guidelines

Posted by  | Prevention/Screening

What cancer screenings do I need and when? If this answer isn't clear to you, listen to Kimmel Cancer Center director William Nelson moderate a webinar on "Making Sense of Cancer Screening Guidelines," hosted by the American Association for Cancer Research and Cancer Today magazine. Nelson and his co-panelists will summarize the guidelines and provide their(...)

What’s next for bladder cancer research?

Posted by  | Research

The Johns Hopkins Greenberg Bladder Cancer Institute recently announced a joint effort with the Bladder Cancer Advocacy Network (BCAN) to fund up to two awards totaling $100,000 for young scientists. As part of the announcement, the Institute's director, David McConkey, Ph.D., gave us his thoughts on recent bladder cancer advances and ongoing research. Recent advances, says McConkey, include(...)

Scientists let GENIE data “out of the bottle”

Posted by  | Research

Nearly 19,000 de-identified genomic records from cancer patients treated by an international group of hospitals, including the Johns Hopkins Kimmel Cancer Center, have been collected in a database coordinated by the American Association for Cancer Research (AACR) and are now available to scientists across the globe. The data was gathered from the genomic sequencing of(...)

5 Things We Learned About Immunotherapy This Year

Posted by  | Research

Immunotherapy has become one of the hottest areas of cancer research, and the number of cancers successfully treated by immunotherapy is growing. Nearing the end of 2016, there are now four FDA-approved immunotherapy drugs that target immune system checkpoints to treat six types of cancer. We asked Drew Pardoll, M.D., Ph.D., director of the Bloomberg~Kimmel(...)

President Obama Signs 21st Century Cures Act

Posted by  | Research

A ceremony was held yesterday at the White House to sign the 21st Century Cures Act, which authorizes $4.8 billion in National Institutes of Health funding for a broad range of biomedical initiatives, including cancer and precision medicine. Immunotherapy patient Stefani Joho [watch a video of Stefani's story] and Dr. Elizabeth Jaffee, deputy director of the(...)